Agilent Technologies (A) Earning Somewhat Positive News Coverage, Report Finds
News coverage about Agilent Technologies (NYSE:A) has been trending somewhat positive recently, Accern Sentiment reports. The research firm identifies negative and positive news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Agilent Technologies earned a daily sentiment score of 0.20 on Accern’s scale. Accern also assigned media coverage about the medical research company an impact score of 46.8181026577178 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.
Here are some of the news headlines that may have impacted Accern Sentiment’s analysis:
- Agilent Technologies (A) Q1 2018 Earnings Conference Call Transcript (finance.yahoo.com)
- Q3 2018 EPS Estimates for Agilent Technologies Inc Raised by Jefferies Group (A) (americanbankingnews.com)
- Accelerate Diagnostics (AXDX) vs. Agilent Technologies (A) Financial Review (americanbankingnews.com)
- Agilent Technologies Inc Forecasted to Earn Q3 2018 Earnings of $0.63 Per Share (A) (americanbankingnews.com)
- Jefferies Group Equities Analysts Decrease Earnings Estimates for Agilent Technologies Inc (A) (americanbankingnews.com)
Agilent Technologies (A) traded down $0.89 during trading hours on Tuesday, hitting $71.08. 2,579,405 shares of the stock were exchanged, compared to its average volume of 2,420,000. Agilent Technologies has a twelve month low of $50.58 and a twelve month high of $75.00. The company has a market cap of $22,960.00, a PE ratio of 31.73, a P/E/G ratio of 2.41 and a beta of 1.28. The company has a quick ratio of 2.78, a current ratio of 3.23 and a debt-to-equity ratio of 0.40.
Several research analysts have issued reports on A shares. JPMorgan Chase & Co. increased their target price on shares of Agilent Technologies from $75.00 to $80.00 and gave the stock an “overweight” rating in a report on Thursday, February 15th. Cowen reiterated a “hold” rating and set a $70.00 target price on shares of Agilent Technologies in a report on Wednesday, November 22nd. Robert W. Baird reiterated a “buy” rating and set a $72.00 target price on shares of Agilent Technologies in a report on Friday, November 24th. Evercore ISI started coverage on shares of Agilent Technologies in a report on Wednesday, January 3rd. They set an “outperform” rating and a $75.00 target price on the stock. Finally, Zacks Investment Research upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating and set a $76.00 target price on the stock in a report on Tuesday, October 31st. Five equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. Agilent Technologies has an average rating of “Buy” and a consensus price target of $70.98.
In other news, insider Patrick Kaltenbach sold 7,358 shares of the firm’s stock in a transaction dated Wednesday, November 22nd. The shares were sold at an average price of $69.28, for a total value of $509,762.24. Following the sale, the insider now directly owns 72,862 shares in the company, valued at approximately $5,047,879.36. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Michael R. Mcmullen sold 43,703 shares of the firm’s stock in a transaction dated Friday, January 5th. The shares were sold at an average price of $70.00, for a total transaction of $3,059,210.00. Following the completion of the sale, the chief executive officer now owns 302,837 shares in the company, valued at $21,198,590. The disclosure for this sale can be found here. Insiders sold a total of 175,029 shares of company stock worth $12,349,106 over the last 90 days.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.